Deep Learning-based Automated Segmentation of Organs at Risk in Treat Head and Neck Radiotherapy


About this study

The purpose of this study is to validate the ability of GHMCA to produce expert-level contouring on retrospective Mayo data with a considerable time savings benefit.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Mayo Clinic Department of Radiation Oncology staff from the Midwest and Arizona, specifically physicians, certified medical dosimetrists (CMD), and medical dosimetry assistants (MDA) familiar with the radiation treatment planning of H&N cancer patients in routine clinical care.

Exclusion Criteria:

  • Mayo Clinic Department of Radiation Oncology staff (enterprise-wide) involved with the training of the GHMCA.

Eligibility last updated 9/28/21. Questions regarding updates should be directed to the study team contact.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Samir Patel, M.D.

Open for enrollment

Contact information:

Justine Buroker M.B.A., CCRP

(507) 293-0624

More information


Publications are currently not available

Mayo Clinic Footer